| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 146.63× | 146.63× | 122.77× | 122.03× | 124.99× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.04× | 1.06× | 1.20× | 1.32× | 1.77× | ||
| 0.70× | 0.70× | 0.80× | 0.82× | 0.80× | ||
| 0.77× | 0.77× | 0.68× | 1.12× | 0.77× | ||
| 0.57× | 0.57× | 0.57× | 0.98× | 0.64× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 124.99 | 122.03 | 122.77 | 146.63 | 146.63 | |
| Working Capital Turnover | 1.77 | 1.32 | 1.20 | 1.06 | 1.04 | |
| Asset Turnover | 0.80 | 0.82 | 0.80 | 0.70 | 0.70 | |
| Cash Conversion (CFO/Net Income) | 0.77 | 1.12 | 0.68 | 0.77 | 0.77 | |
| CFO/EBITDA | 0.64 | 0.98 | 0.57 | 0.57 | 0.57 |